(Q38053092)

27 August 2017

title

Disseminated amphotericin-resistant fusariosis in acute leukemia patients: report of two cases (English)

1 reference

27 August 2017

1 reference

Graziella Hanna Pereira

1

1 reference

27 August 2017

Derlene Attili de Angelis

2

1 reference

27 August 2017

Roosecelis Araujo Brasil

3

1 reference

27 August 2017

Marilena dos Anjos Martins

4

1 reference

27 August 2017

Dulcilena de Matos Castro e Silva

5

1 reference

27 August 2017

Maria Walderez Szeszs

6

1 reference

27 August 2017

Marcia de Souza Carvalho Melhem

7

1 reference

27 August 2017

publication date

18 October 2012

1 reference

27 August 2017

number of pages

8

1 reference

inferred from page(s)

published in

Mycopathologia

1 reference

27 August 2017

volume

175

1 reference

27 August 2017

issue

1-2

1 reference

27 August 2017

page(s)

107-114

1 reference

https://scigraph.springernature.com/pub.10.1007/s11046-012-9585-0

27 August 2017

exact match

0 references

cites work

Disseminated fusariosis caused by Fusarium verticillioides in an acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

Invasive fusariosis with prolonged fungemia in a patient with acute lymphoblastic leukemia: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

Outcome determinants of fusariosis in a tertiary care cancer center: the impact of neutrophil recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

Fusarium infections in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

The epidemiology of fusariosis in patients with haematological diseases. Gimema Infection Programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

Clinical patterns of Fusarium infections in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

The ins and outs of DNA fingerprinting the infectious fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

Prospective study of fungaemia in a single cancer institution over a 10-y period: aetiology, risk factors, consumption of antifungals and outcome in 140 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

Taxonomy, biology, and clinical aspects of Fusarium species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

Less-frequent Fusarium species of clinical interest: correlation between morphological and molecular identification and antifungal susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

New species from the Fusarium solani species complex derived from perithecia and soil in the old World tropics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

Evaluation of Fusarium solani hyphae and conidia susceptibility to amphotericin B and itraconazole: study of a clinical case.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

Successful medical management of recalcitrant Fusarium solani keratitis: molecular identification and susceptibility patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

Fusarium infection in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

Fusarium infection in lung transplant patients: report of 6 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

AMPLIFICATION AND DIRECT SEQUENCING OF FUNGAL RIBOSOMAL RNA GENES FOR PHYLOGENETICS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9585-0

In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains

21 January 2018

1 reference

12 December 2020

Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management

1 reference

12 December 2020

In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens.

1 reference

12 December 2020

Fusarium infections of the skin.

1 reference

12 December 2020

The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study

1 reference

12 December 2020

A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B

1 reference

12 December 2020

Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species

1 reference

12 December 2020

In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens.

1 reference

12 December 2020

Fungaemia survey: a 10-year experience in Bergamo, Italy

1 reference

12 December 2020

Itraconazole resistance in Aspergillus fumigatus

1 reference

12 December 2020

10.1007/S11046-012-9585-0

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1048478266

0 references

1 reference